Amwill Health Care Limited (BOM:544353)
India · Delayed Price · Currency is INR 43.14
0.00 (0.00%)
At close: Oct 16, 2026
Amwill Health Care Revenue
In the fiscal year ending March 31, 2026, Amwill Health Care had annual revenue of 454.92M INR with 12.10% growth. Amwill Health Care had revenue of 242.87M in the half year ending March 31, 2026. That makes Amwill Health Care the 40,092nd largest company in the world by revenue and 3,824th in India.
Revenue
454.92M
Revenue Growth
+12.10%
P/S Ratio
1.90
Revenue / Employee
5.17M
Employees
88
Market Cap
862.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 454.92M | 49.11M | 12.10% |
| Mar 31, 2025 | 405.82M | -33.67M | -7.66% |
| Mar 31, 2024 | 439.48M | 137.82M | 45.69% |
| Mar 31, 2023 | 301.66M | 25.53M | 9.25% |
| Mar 31, 2022 | 276.13M | 96.14M | 53.41% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Concord Drugs | 860.69M |
| Source Natural Foods and Herbal Supplements | 796.24M |
| Mercury Laboratories | 737.65M |
| Shelter Pharma | 731.34M |
| Onyx Biotec | 694.69M |
| Cian Healthcare | 282.99M |
| Asston Pharmaceuticals | 254.69M |
| Pharmaids Pharmaceuticals | 253.40M |